Fucoxanthin reduces fat through multiple mechanisms: it inhibits fat synthesis and storage, increases fatty acid oxidation, and stimulates UCP1 in white adipose tissue to promote thermogenesis and energy expenditure
Proposed mechanisms include: firstly, vitamin K exerts the inhibition of lipopolysaccharide (LPS)-induced nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation and the suppression of NF-B pathway signaling, thereby decreasing pro-inflammatory cytokines such as IL-6 and TNF- (34)
Journal of Biological Chemistry, 281 (27), 18774-18786
Pharmacognosy Phytochem
As such, it is sold strictly as a research chemical and labeled not for human consumption. United States Legal Status BPC-157 is not FDA-approved for any medical or therapeutic use It is legal to buy and possess for research purposes It cannot be marketed or sold for human use , which includes claims related to healing or supplementation Companies distributing it for human use risk FDA enforcement actions , including warning letters and product seizures FDA considers products like BPC-157 that are sold for use in humans without proper approval to be unapproved new drugs, subject to regulatory enforcement. U.S
